Bioviser
Bioviser is a global healthcare and pharmaceutical consulting company dedicated to advancing healthcare through scientific expertise, innovative solutions, and strategic partnerships. They offer a wide range of services including pharmacovigilance, health economics, publication planning, space research, biostatistics, and data analytics. Committed to quality, transparency, and client success, Bioviser leverages technology and scientific knowledge to address complex health challenges and improve patient outcomes worldwide. The company actively engages in cutting-edge research, clinical solutions, and evidence-based health strategies, supporting publication and manuscript writing for global pharmaceutical clients. They also provide expert HEOR services, space health research, and have a strong focus on evidence-based health solutions.
Industries
Nr. of Employees
small (1-50)
Products
Regulatory Writing for
Specialized regulatory medical writing services including clinical overviews, clinical summaries, and clinical study reports for eCTD submissions.
Regulatory Writing for Medical Devices
Targeted regulatory writing and evaluation services tailored specifically to medical device compliance under EU MDR and related frameworks.
Health Economics & Value and HEOR Analysis
Comprehensive Health Economics and Outcomes Research (HEOR) analytics and consulting services designed to demonstrate the economic benefit of healthcare products and facilitate drug approval, reimbursement, and formulary listing.
Case Processing Support
End-to-end case processing support including intake, triage, data entry, quality review, medical review, and regulatory submission.
Expert engagement
Services designed to facilitate meaningful engagement with Key Opinion Leaders (KOLs) and medical experts.
Real-World Evidence Solutions
Bioviser’s expertise in generating real-world evidence (RWE) from real world data using bespoke methodologies, supporting regulatory, healthcare, and product lifecycle management decisions.
Regulatory Writing for
Specialized regulatory medical writing services including clinical overviews, clinical summaries, and clinical study reports for eCTD submissions.
Regulatory Writing for Medical Devices
Targeted regulatory writing and evaluation services tailored specifically to medical device compliance under EU MDR and related frameworks.
Health Economics & Value and HEOR Analysis
Comprehensive Health Economics and Outcomes Research (HEOR) analytics and consulting services designed to demonstrate the economic benefit of healthcare products and facilitate drug approval, reimbursement, and formulary listing.
Case Processing Support
End-to-end case processing support including intake, triage, data entry, quality review, medical review, and regulatory submission.
Expert engagement
Services designed to facilitate meaningful engagement with Key Opinion Leaders (KOLs) and medical experts.
Real-World Evidence Solutions
Bioviser’s expertise in generating real-world evidence (RWE) from real world data using bespoke methodologies, supporting regulatory, healthcare, and product lifecycle management decisions.
Services
Design and execution of studies using real-world data to address clinical and market-access evidence needs, including study design, data curation and analysis.
Development of economic models, systematic literature reviews, cost-effectiveness and budget-impact analyses and preparation of value dossiers to inform pricing, reimbursement and market-access strategies.
Managed pharmacovigilance services including case processing (ICSR), safety database operations, coding, medical assessment and regulatory reporting with audit-ready documentation and quality oversight.
Preparation and consolidation of aggregate safety reports for regulatory and compliance needs across multiple jurisdictions.
End-to-end manuscript preparation, journal submission management, peer-review response drafting and publication-policy/SOP development for clinical and observational research.
Medical writing, publication planning, medical review and communication strategies to support scientific dissemination and stakeholder engagement.
Design and execution of studies using real-world data to address clinical and market-access evidence needs, including study design, data curation and analysis.
Development of economic models, systematic literature reviews, cost-effectiveness and budget-impact analyses and preparation of value dossiers to inform pricing, reimbursement and market-access strategies.
Managed pharmacovigilance services including case processing (ICSR), safety database operations, coding, medical assessment and regulatory reporting with audit-ready documentation and quality oversight.
Preparation and consolidation of aggregate safety reports for regulatory and compliance needs across multiple jurisdictions.
End-to-end manuscript preparation, journal submission management, peer-review response drafting and publication-policy/SOP development for clinical and observational research.
Medical writing, publication planning, medical review and communication strategies to support scientific dissemination and stakeholder engagement.
Expertise Areas
- Real-world evidence and RWD analytics
- Claims-database epidemiology and transmission modelling
- Health economics (HEOR) and value-dossier development
- Pharmacovigilance and safety database operations
Key Technologies
- Real-world data (RWD) analytics
- Claims database analysis
- Epidemiological and transmission modelling
- Health-economic modelling and budget-impact analysis
News & Updates
Bioviser helped a distinguished pharma company clear a backlog of cases by onboarding associates and assisted with USFDA audit preparation, resulting in no findings or observations.
Bioviser participated in the Human Research Program Investigators’ Workshop (HRP IWS) in Galveston, TX, focusing on safe and efficient human spaceflight.
Bioviser presented on the public disclosure of clinical research and evidence transparency at the ISPOR 2023 conference.
Analysis of the impact of U.S. drug pricing policies on the global pharmaceutical industry.
Exploring how space research data analytics support clinical and translational research.
Bioviser helped a distinguished pharma company clear a backlog of cases by onboarding associates and assisted with USFDA audit preparation, resulting in no findings or observations.
Bioviser participated in the Human Research Program Investigators’ Workshop (HRP IWS) in Galveston, TX, focusing on safe and efficient human spaceflight.
Bioviser presented on the public disclosure of clinical research and evidence transparency at the ISPOR 2023 conference.
Analysis of the impact of U.S. drug pricing policies on the global pharmaceutical industry.
Exploring how space research data analytics support clinical and translational research.